Hemetron

Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.

Health and bioData and analyticsDeveloper tools and cloud

Hemetron has no funding amount on record yet; its latest known round is Pre Seed (May 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• AT
  Alexander Tanno Founder

  source: crunchbase.com

Raise history

1. May 31, 2026
   Pre Seed · amount undisclosed
   Source: crunchbase.com

Related bio health companies

• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026
• FFreyyaSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/hemetron.